BRIEF published on 10/15/2025 at 07:35, 1 month 20 days ago EUROPLASMA reduces its capital due to losses Decarbonization Investment Europlasma Capital Reduction Decontamination
BRIEF published on 10/15/2025 at 07:35, 1 month 20 days ago Capital reduction at Europlasma Decarbonization Actions Europlasma Capital Reduction Decontamination
BRIEF published on 10/06/2025 at 18:05, 1 month 29 days ago EUROPLASMA completes its share consolidation operations Share Consolidation Europlasma Euronext Growth ISIN Decontamination
BRIEF published on 10/06/2025 at 10:30, 1 month 29 days ago EUROPLASMA: Voting Rights and Shares Balance Sheet as of September 30, 2025 Voting Rights Europlasma Industry Shares Outstanding Decontamination
BRIEF published on 10/06/2025 at 10:30, 1 month 29 days ago EUROPLASMA Declares Its Share Capital as of September 30, 2025 Share Capital Voting Rights Europlasma Euronext Growth Regulation
BRIEF published on 09/30/2025 at 18:20, 2 months 4 days ago Europlasma reveals the number of shares subject to the consolidation Europlasma Euronext Growth Dilutive Financing Decontamination Grouping Actions
BRIEF published on 09/23/2025 at 18:05, 2 months 11 days ago Europlasma: Results of the 2025 General Meeting Europlasma Resolutions General Assembly Quorum 2024 Accounts
BRIEF published on 09/11/2025 at 18:05, 2 months 23 days ago Europlasma positions itself for the takeover of NovAsco sites Europlasma Judicial Recovery Resumption NovAsco Steels
BRIEF published on 09/05/2025 at 18:50, 2 months 29 days ago EUROPLASMA: Preparations for the General Meeting of September 2025 Shareholders Share Capital Europlasma General Meeting Preparatory Documents
BRIEF published on 09/05/2025 at 18:35, 2 months 29 days ago Europlasma announces the issue of €2 million in convertible bonds Convertible Bonds Europlasma Growth Dilution EPF
Published on 12/05/2025 at 02:35, 4 hours 32 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 7 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 2 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 7 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 36 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 16 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 41 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 52 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 56 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 13 hours 7 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 22 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 23 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
